Cardiovascular Medicine Book

Congestive Heart Failure

Coronary Artery Disease

Electrocardiogram

Examination

Hyperlipidemia

Hypertension

Miscellaneous

Pericardial Disorders

Obstetrics Chapter related topics

http://www.fpnotebook.com/

Isoproterenol

Advertisement

  1. Pathophysiology
    1. Synthetic Sympathomimetic amine
    2. Pure Beta adrenergic agonist
      1. Potent Chronotropic effects
        1. Increases Heart Rate
        2. Potentiates AV conduction
      2. Potent Inotropic effects
        1. Increases cardiac contractility
        2. Markedly increases cardiac output
      3. Causes Peripheral vasodilatation
        1. Decreases Diastolic pressure
      4. Causes Bronchodilation
    3. Markedly increases myocardial oxygen demand
      1. May provoke Myocardial Ischemia
      2. May decrease coronary perfusion
  2. Pharmacokinetics
    1. Very short half-life (<1.5 minutes)
  3. Indications
    1. Other inotropic agents preferred over Isoproterenol
      1. Dobutamine
      2. Amrinone
    2. Hemodynamically significant Bradycardia (pulse present)
      1. Specific Uses
        1. Heart Block
        2. Bradycardia in denervated transplanted heart
      2. Unresponsive to other measures
        1. Atropine
        2. Epinephrine
        3. Transcutaneous pacing or transvenous pacing
        4. Dopamine
  4. Contraindication
    1. Ischemic Heart Disease
  5. Pediatric Infusion (Same as Epinephrine preparation)
    1. Preparation
      1. Draw up "x" mg of Isoproterenol
      2. Where "x" = 0.6 x Weight in Kilograms
      3. Add enough D5W or NS for 100 ml total
      4. At this dilution:
        1. Infusion rate of 1 ml/h provides 0.1 ug/kg/min
    2. Start Dose: 10 ml/hour (10 ug/kg/min)
    3. Titrate to clinical response, adjusting every 5 min
  6. Adult Infusion
    1. Preparation
      1. Dissolve 1 mg Isoproterenol in 250 ml D5W
      2. Final Concentration: 4 ug/ml
    2. Start Dose: 2 ug/min
    3. Titrate: 2-10 ug/min to clinical response
      1. Heart Rate over 60 beats per minute
  7. Precautions
    1. Decreases Diastolic Blood Pressure
      1. No alpha adrenergic effect
      2. Increases Heart Rate (less diastolic filling time)
    2. May precipitate Myocardial Ischemia
      1. Increases myocardial oxygen demand
      2. Decreases coronary perfusion
    3. Induces arrhythmias
      1. Ventricular Tachycardia
      2. Ventricular Fibrillation
    4. Exacerbates tachyarrhythmias due to Digitalis Toxicity
    5. Precipitates Hypokalemia

Isoproterenol (C0022245)

Definition (MSH)Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
Definition (CSP)synthetic adrenergic agent derived from norepinephrine, having powerful bronchodilator and cardiac stimulant action.
Definition (NCI)A synthetic catechol compound and potent beta adrenergic agonist with peripheral vasodilator, bronchodilator, and cardiac stimulating properties. Isoproterenol exerts its effect on the beta1-receptors in the myocardium, thereby increasing heart rate and cardiac output. In addition, isoproterenol acts on beta2-receptors in bronchiolar and vascular smooth muscle, thereby causing smooth muscle relaxation.
ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
MSHD007545
EnglishIsoprenaline, Isopropyl Noradrenaline, Isopropylarterenol, Isopropylnoradrenaline, Isopropylnorepinephrine, Isoproterenol, ISOPROTERENOL PREPARATION, Isoproteronol
Spanishisoprenalina, isoproterenol, isoproteronol
Parent ConceptsEthanolamines (C0014983), Adrenergic Agents (C0001637), Bronchodilator Agents (C0006280), Catecholamines (C0007412), [AU100] SYMPATHOMIMETICS (ADRENERGICS) (C0973492), [RE102] BRONCHODILATORS, SYMPATHOMIMETIC,INHALATION (C0973617), Adrenergic beta-Agonists (C0001644), Bronchodilators, Sympathomimetic (C1579392)
SourcesAOD, CSP, LCH, MSH, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF
Derived from the NIH UMLS (Unified Medical Language System)



Navigation Tree